M. Eugenia Socías

4.3k total citations
145 papers, 2.8k citations indexed

About

M. Eugenia Socías is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, M. Eugenia Socías has authored 145 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Epidemiology, 71 papers in Public Health, Environmental and Occupational Health and 33 papers in Infectious Diseases. Recurrent topics in M. Eugenia Socías's work include Opioid Use Disorder Treatment (69 papers), HIV, Drug Use, Sexual Risk (46 papers) and Substance Abuse Treatment and Outcomes (39 papers). M. Eugenia Socías is often cited by papers focused on Opioid Use Disorder Treatment (69 papers), HIV, Drug Use, Sexual Risk (46 papers) and Substance Abuse Treatment and Outcomes (39 papers). M. Eugenia Socías collaborates with scholars based in Canada, United States and Argentina. M. Eugenia Socías's co-authors include Thomas Kerr, M‐J Milloy, Evan Wood, Omar Sued, Kanna Hayashi, Brandon D. L. Marshall, Edward J. Mills, Nathan Ford, Steve Kanters and Kristian Thorlund and has published in prestigious journals such as JAMA, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

M. Eugenia Socías

129 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Eugenia Socías Canada	30	1.3k	920	823	359	340	145	2.8k
E. Jennifer Edelman United States	34	2.2k 1.7×	1.4k 1.5×	1.6k 1.9×	261 0.7×	921 2.7×	210	4.1k
Bohdan Nosyk Canada	35	2.8k 2.2×	2.0k 2.2×	1.4k 1.7×	388 1.1×	607 1.8×	186	4.4k
Heather Bradley United States	28	2.0k 1.6×	459 0.5×	1.9k 2.3×	436 1.2×	786 2.3×	108	4.1k
Kamyar Arasteh United States	28	2.0k 1.6×	602 0.7×	1.2k 1.5×	216 0.6×	426 1.3×	94	2.6k
Glenn‐Milo Santos United States	33	2.0k 1.6×	898 1.0×	1.8k 2.2×	337 0.9×	690 2.0×	113	3.6k
Kanna Hayashi Canada	32	3.0k 2.4×	2.2k 2.4×	818 1.0×	142 0.4×	662 1.9×	275	4.1k
Paula J. Lum United States	29	2.3k 1.9×	879 1.0×	1.1k 1.3×	215 0.6×	484 1.4×	77	3.0k
Denise Paone United States	30	2.3k 1.8×	1.3k 1.4×	1.2k 1.5×	135 0.4×	976 2.9×	76	3.4k
Mohammad Karamouzian Canada	32	1.7k 1.4×	1.1k 1.2×	1.0k 1.2×	66 0.2×	630 1.9×	147	3.5k
Vivian Hope United Kingdom	40	3.9k 3.1×	1.3k 1.4×	1.6k 1.9×	203 0.6×	424 1.2×	147	5.0k

Countries citing papers authored by M. Eugenia Socías

Since Specialization

Citations

This map shows the geographic impact of M. Eugenia Socías's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Eugenia Socías with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Eugenia Socías more than expected).

Fields of papers citing papers by M. Eugenia Socías

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Eugenia Socías. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Eugenia Socías. The network helps show where M. Eugenia Socías may publish in the future.

Co-authorship network of co-authors of M. Eugenia Socías

This figure shows the co-authorship network connecting the top 25 collaborators of M. Eugenia Socías. A scholar is included among the top collaborators of M. Eugenia Socías based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Eugenia Socías. M. Eugenia Socías is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hossain, Md. Belal, Jeong Eun Min, Mohammad Ehsanul Karim, et al.. (2025). Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelines. BMJ Open. 15(3). e095198–e095198.

Hossain, Md. Belal, Jeong Eun Min, Micah Piske, et al.. (2025). Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada. BMJ Open. 15(9). e098990–e098990.

Socías, M. Eugenia, Eric C. Sayre, Kanna Hayashi, et al.. (2025). Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain. Drug and Alcohol Review. 44(3). 799–810.

Scheuermeyer, Frank, Skye Barbic, M. Eugenia Socías, & Amanda Slaunwhite. (2025). Sex differences in the 1-year outcomes of emergency department patients with alcohol withdrawal. Canadian Journal of Emergency Medicine. 28(2). 144–149.

Bach, Paxton, M. Eugenia Socías, Nadia Fairbairn, et al.. (2025). Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020. Drug and Alcohol Dependence. 273. 112703–112703. 2 indexed citations

Cui, Zishan, et al.. (2024). Redesigning a Stopped Clinical Trial as an Emulated Trial Using Real-World Data to Explore the Effectiveness of Slow-Release Oral Morphine as a Treatment for Opioid Use Disorder. PubMed. 46(2). 384–390.

Fairbairn, Nadia, et al.. (2024). Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada. American Journal on Addictions. 33(6). 664–674. 3 indexed citations

Socías, M. Eugenia, et al.. (2024). Mediating effect of craving on the impact of buprenorphine/naloxone and methadone treatment on opioid use: Results from a randomized controlled trial. Addictive Behaviors. 154. 108023–108023. 2 indexed citations

Socías, M. Eugenia, et al.. (2024). Associations of Methadone and BUP/NX Dose Titration Patterns With Retention in Treatment and Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: Secondary Analysis of the OPTIMA Study. Journal of Addiction Medicine. 18(2). 167–173. 2 indexed citations

10.

Socías, M. Eugenia, et al.. (2024). Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial. Journal of Dual Diagnosis. 20(3). 189–200. 2 indexed citations

11.

Reddon, Hudson, M. Eugenia Socías, Kora DeBeck, et al.. (2023). Cannabis use to manage stimulant cravings among people who use unregulated drugs. Addictive Behaviors. 148. 107867–107867. 3 indexed citations

12.

Whitehurst, David G. T., Emanuel Krebs, Benjamin Enns, et al.. (2023). Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada. Quality of Life Research. 32(8). 2209–2221. 2 indexed citations

13.

Chenoweth, Meghan J., Didier Jutras‐Aswad, Keith Ahamad, et al.. (2023). Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical Pharmacology & Therapeutics. 115(3). 506–514.

14.

Tatar, Ovidiu, et al.. (2023). Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the OPTIMA study. American Journal on Addictions. 32(5). 469–478. 12 indexed citations

15.

Socías, M. Eugenia, et al.. (2022). Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies. Drug and Alcohol Review. 42(3). 538–543. 13 indexed citations

16.

Lake, Stephanie, Jane A. Buxton, Zach Walsh, et al.. (2022). Methadone Dose, Cannabis Use, and Treatment Retention: Findings From a Community-based Sample of People Who Use Unregulated Drugs. Journal of Addiction Medicine. 17(1). e18–e26. 4 indexed citations

17.

Hassan, Ahmed N., Nikki Bozinoff, Didier Jutras‐Aswad, et al.. (2022). Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial. Journal of Addiction Medicine. 17(1). e49–e56. 3 indexed citations

18.

Lake, Stephanie, Thomas Kerr, Jane A. Buxton, et al.. (2021). The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs. Cannabis and Cannabinoid Research. 8(1). 155–165. 9 indexed citations

19.

Argento, Elena, M. Eugenia Socías, Kanna Hayashi, et al.. (2021). Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting. International Journal of Drug Policy. 100. 103518–103518. 18 indexed citations

20.

Ghiglione, Yanina, Juliana Falivene, M. Eugenia Socías, et al.. (2014). HIV-1 Env-specific IgA/IgG Ratio Is Related to Antibody Dependent Cellular Cytotoxicity (ADCC) Responses Observed during Acute/Early HIV Infection. AIDS Research and Human Retroviruses. 30(S1). A89–A89. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact